Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bernatowska

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Gut|July 1, 1989
Interaction of campylobacter species with antibody, complement and phagocytesE Bernatowska, P Jose, H Davies, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1985
Immunoglobulin synthesis by lymphocytes of eight immuno-deficient childrenE Bernatowska, A Górski, G Korczak-Kowalska, et al.
Clinical and Experimental Immunology|August 1, 1991
Clinical efficacy of intravenous immunoglobulin in patients with severe inflammatory chest disease and IgG3 subclass deficiencyE Bernatowska-Matuszkiewicz, M Pac, H Skopcynska, et al.
Clinical and Experimental Immunology|June 17, 2010
A multi-centre study of efficacy and safety of Intratect®, a novel intravenous immunoglobulin preparationW Kreuz, M Erdös, P Rossi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 30, 2011
Antibody response to Haemophilus influenzae type-b conjugate vaccine in children and young adults with congenital asplenia or after undergoing splenectomyB Mikoluc, R Motkowski, H Käyhty, et al.
Vox Sanguinis|April 3, 2003
Pharmacokinetics of total immunoglobulin G and immunoglobulin G subclasses in patients undergoing replacement therapy for primary immunodeficiency syndromesM-A Alyanakian, E Bernatowska, J-M Scherrmann, et al.
Immunological Investigations|April 1, 1991
IgG subclasses and antibody response to pneumococcal capsular polysaccharides in children with severe sinopulmonary infections and asthmaE Bernatowska-Matuszkiewicz, M Pac, M Pum, et al.
Vox Sanguinis|May 9, 2015
An open, prospective trial investigating the pharmacokinetics and safety, and the tolerability of escalating infusion rates of a 10% human normal immunoglobulin for intravenous infusion (IVIg), BT090, in patients with primary immunodeficiency diseaseG Kriván, Ch Königs, E Bernatowska, et al.
European Journal of Pediatrics|September 20, 1997
A European phase II study of recombinant human granulocyte colony-stimulating factor (lenograstim) in the treatment of severe chronic neutropenia in children. Lenograstim Study GroupJ Donadieu, P Boutard, E Bernatowska, et al.
Clinical Immunology and Immunopathology|May 1, 1987
Results of a prospective controlled two-dose crossover study with intravenous immunoglobulin and comparison (retrospective) with plasma treatmentE Bernatowska, K Madaliński, W Janowicz, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Gut|July 1, 1989
Interaction of campylobacter species with antibody, complement and phagocytesE Bernatowska, P Jose, H Davies, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1985
Immunoglobulin synthesis by lymphocytes of eight immuno-deficient childrenE Bernatowska, A Górski, G Korczak-Kowalska, et al.
Clinical and Experimental Immunology|August 1, 1991
Clinical efficacy of intravenous immunoglobulin in patients with severe inflammatory chest disease and IgG3 subclass deficiencyE Bernatowska-Matuszkiewicz, M Pac, H Skopcynska, et al.
Clinical and Experimental Immunology|June 17, 2010
A multi-centre study of efficacy and safety of Intratect®, a novel intravenous immunoglobulin preparationW Kreuz, M Erdös, P Rossi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 30, 2011
Antibody response to Haemophilus influenzae type-b conjugate vaccine in children and young adults with congenital asplenia or after undergoing splenectomyB Mikoluc, R Motkowski, H Käyhty, et al.
Vox Sanguinis|April 3, 2003
Pharmacokinetics of total immunoglobulin G and immunoglobulin G subclasses in patients undergoing replacement therapy for primary immunodeficiency syndromesM-A Alyanakian, E Bernatowska, J-M Scherrmann, et al.
Immunological Investigations|April 1, 1991
IgG subclasses and antibody response to pneumococcal capsular polysaccharides in children with severe sinopulmonary infections and asthmaE Bernatowska-Matuszkiewicz, M Pac, M Pum, et al.
Vox Sanguinis|May 9, 2015
An open, prospective trial investigating the pharmacokinetics and safety, and the tolerability of escalating infusion rates of a 10% human normal immunoglobulin for intravenous infusion (IVIg), BT090, in patients with primary immunodeficiency diseaseG Kriván, Ch Königs, E Bernatowska, et al.
European Journal of Pediatrics|September 20, 1997
A European phase II study of recombinant human granulocyte colony-stimulating factor (lenograstim) in the treatment of severe chronic neutropenia in children. Lenograstim Study GroupJ Donadieu, P Boutard, E Bernatowska, et al.
Clinical Immunology and Immunopathology|May 1, 1987
Results of a prospective controlled two-dose crossover study with intravenous immunoglobulin and comparison (retrospective) with plasma treatmentE Bernatowska, K Madaliński, W Janowicz, et al.
Pageof 3